A new 180-day clinical trial found that a simple daily collagen supplement eased pain and stiffness in adults with early knee osteoarthritis, giving millions of achy-kneed Americans a reason to pay attention.
Quick Take
- A randomized, placebo-controlled trial gave 80 adults ages 40 to 75 either 3,000 milligrams of low-molecular-weight collagen peptides or a placebo every day for six months.
- All participants had mild to moderate knee osteoarthritis, confirmed by standard imaging grades.
- A 2023 meta-analysis of earlier trials also found collagen peptides eased knee pain more than placebo.
- Researchers still say collagen type, dose, and study quality vary too much to call it a cure-all for joint pain.
What The New Trial Actually Found
Researchers ran a double-blind, placebo-controlled trial on 80 adults with Kellgren-Lawrence grade one or two knee osteoarthritis, a scale doctors use to rate how worn down a joint looks on an X-ray. Half the group took 3,000 milligrams of low-molecular-weight collagen peptides daily. The other half took a placebo. Neither the patients nor the researchers knew who got which, for six full months.
That design matters. Double-blind, placebo-controlled trials are the gold standard in medicine because they strip out wishful thinking. If people taking a sugar pill felt just as good as people taking collagen, the supplement would get no credit. Instead, the collagen group showed meaningful improvement in pain and joint function over placebo by the end of the study.
This Is Not The First Study To Find This
The 2025 trial joins a growing stack of research on collagen and joints. A separate randomized trial testing a combination of undenatured type two collagen and hydrolyzed collagen also reported improved knee osteoarthritis symptoms over six months of daily tablets. Another study gave participants 10 grams of hydrolyzed collagen daily and tracked pain relief against a placebo group over the same six-month window, with similar encouraging results.
A 2023 meta-analysis pooled data from multiple randomized trials and found a statistically significant difference in pain relief between people taking collagen peptides and those on placebo. That is the kind of result that moves a supplement from “maybe” to “worth a real conversation with your doctor.” For people managing daily knee pain without wanting to live on ibuprofen, that distinction carries weight.
Why Doctors Still Hedge Their Bets
Collagen is not one single product. Trials test different forms, including hydrolyzed collagen, undenatured type two collagen, and specific bioactive peptides, at doses ranging from 40 milligrams to 10 grams a day. A review in a European rheumatology journal pointed out that most current guidelines either hold off on recommending collagen or call the evidence uncertain, mainly because trial designs differ so widely.
An umbrella review covering collagen’s effects on joints and skin found real improvements in pain scores and stiffness, with researchers rating the certainty of evidence as high for some measures but not others. That split result is common in supplement science. Early trials spark excitement, a meta-analysis finds a real signal, and then reviewers remind everyone that dose, collagen type, and patient population still need sorting out.
What This Means For Someone With Achy Knees
None of this means collagen replaces physical therapy, weight management, or a doctor’s guidance for osteoarthritis. But the newest trial adds solid data to a pattern that keeps repeating across multiple independent studies: people taking daily collagen peptides tend to report less knee pain and better function than people taking placebo pills. For a supplement with a strong safety record and growing trial support, that is a reasonable thing to discuss at your next checkup.
Joint pain is one of the most common complaints among Americans over 40, and the appetite for a non-drug option is only growing. Collagen will not fix every knee, and researchers are honest that more standardized, long-term trials are needed before guidelines change. Still, the trial lineup now stretching back several years gives everyday people a research-backed reason to try it, rather than just a marketing claim on a supplement bottle.
Sources:
mindbodygreen.com, nature.com, pmc.ncbi.nlm.nih.gov, journals.lww.com
